Intranasal influenzavirus vaccine in children. Edwards KM, Dupont WD (1998) N Engl J Med 339: 922; author reply 922-3 Discontinuing nasal steroids might lower intraocular pressure in glaucoma. Bui CM, Chen H, Shyr Y, Joos KM (2005) J Allergy Clin Immunol 116: 1042-7 CaMKII is essential for the proasthmatic effects of oxidation. Sanders PN, Koval OM, Jaffer OA, Prasad AM, Businga TR, Scott JA, Hayden PJ, Luczak ED, Dickey DD, Allamargot C, Olivier AK, Meyerholz DK, Robison AJ, Winder DG, Blackwell TS, Dworski R, Sammut D, Wagner BA, Buettner GR, Pope RM, Miller FJ, Dibbern ME, Haitchi HM, Mohler PJ, Howarth PH, Zabner J, Kline JN, Grumbach IM, Anderson ME (2013) Sci Transl Med 5: 195ra97 Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Crowe JE, Murphy BR, Chanock RM, Williamson RA, Barbas CF, Burton DR (1994) Proc Natl Acad Sci U S A 91: 1386-90 Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Simor AE, Phillips E, McGeer A, Konvalinka A, Loeb M, Devlin HR, Kiss A (2007) Clin Infect Dis 44: 178-85 A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. Edwards KM, Dupont WD, Westrich MK, Plummer WD, Palmer PS, Wright PF (1994) J Infect Dis 169: 68-76 Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus. Fisher RG, Crowe JE, Johnson TR, Tang YW, Graham BS (1999) J Infect Dis 180: 1324-7 An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. Mok H, Tollefson SJ, Podsiad AB, Shepherd BE, Polosukhin VV, Johnston RE, Williams JV, Crowe JE (2008) J Virol 82: 11410-8 Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults. Talbot TR, Crocker DD, Peters J, Doersam JK, Ikizler MR, Sannella E, Wright PE, Edwards KM (2005) Infect Control Hosp Epidemiol 26: 494-500 Dosing feasibility and tolerability of intranasal diazepam in adults with epilepsy. Sperling MR, Haas KF, Krauss G, Seif Eddeine H, Henney HR, Rabinowicz AL, Bream G, Squillacote D, Carrazana EJ (2014) Epilepsia 55: 1544-50 A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens. Galen JE, Gomez-Duarte OG, Losonsky GA, Halpern JL, Lauderbaugh CS, Kaintuck S, Reymann MK, Levine MM (1997) Vaccine 15: 700-8 Efficacy of the novel parainfluenza virus haemagglutinin-neuraminidase inhibitor BCX 2798 in mice - further evaluation. Alymova IV, Watanabe M, Boyd KL, Chand P, Babu YS, Portner A (2009) Antivir Ther 14: 891-8 Chronic invasive fungal sinusitis associated with intranasal drug use. Pekala KR, Clavenna MJ, Shockley R, Weiss VL, Turner JH (2015) Laryngoscope 125: 2656-9 Intranasal dexmedetomidine premedication is comparable with midazolam in burn children undergoing reconstructive surgery. Talon MD, Woodson LC, Sherwood ER, Aarsland A, McRae L, Benham T (2009) J Burn Care Res 30: 599-605
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.